-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I1DP6vEPXeZFcKUtyLqf0TC/xP3k/nznZuOvnYViJCxSdnNI9y1ljztN+IebtiqI ELQyZ6VCbjYRokMmXKsN6A== 0001144204-10-064578.txt : 20101202 0001144204-10-064578.hdr.sgml : 20101202 20101202163543 ACCESSION NUMBER: 0001144204-10-064578 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101202 DATE AS OF CHANGE: 20101202 GROUP MEMBERS: GEMINI STRATEGIES, LLC GROUP MEMBERS: STEVEN WINTERS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-61769 FILM NUMBER: 101228264 BUSINESS ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE #660 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-459-7800 MAIL ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE #660 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GEMINI MASTER FUND LTD CENTRAL INDEX KEY: 0001403092 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: GEMINI STRATEGIES LLC STREET 2: 12220 EL CAMINO REAL STE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 585 480 2828 MAIL ADDRESS: STREET 1: GEMINI STRATEGIES LLC STREET 2: 12220 EL CAMINO REAL STE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 SC 13G 1 v204471_sc13g.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G
(Rule 13d-102)

Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c)
and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2

(AMENDMENT NO.___ )*

Aethlon Medical, Inc.
(Name of Issuer)

Common Stock, $0.001 par value
(Title of Class of Securities)

00808Y109 
(CUSIP Number)

November 22, 2010
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
¨ Rule 13d-1 (b)
x Rule 13d-1 (c)
¨ Rule 13d-1 (d)
 
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
(Continued on following pages)

 
Page 1 of 7 Pages

 

CUSIP No. 00808Y109
13G
Page 2 of 7 Pages
 
1
NAME OF REPORTING PERSON
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
   
 
Gemini Master Fund, Ltd.
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    (a) o
                                                                                                                   (b) x
 
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands
 
  NUMBER OF
  SHARES
  BENEFICIALLY
  OWNED BY
  EACH
5
SOLE VOTING POWER
 
0
  REPORTING
  PERSON WITH 
6
SHARED VOTING POWER
 
7,612,702
 
 
7
SOLE DISPOSITIVE POWER
 
0
 
 
8
SHARED DISPOSITIVE POWER
 
7,612,702
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,612,702
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* o
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
9.75%
 
12
TYPE OF REPORTING PERSON*
 
CO
 
 
* SEE INSTRUCTIONS BEFORE FILLING OUT!

 
 

 

CUSIP No. 00808Y109
13G
Page 3 of 7 Pages
 
1
NAME OF REPORTING PERSON
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
   
 
Gemini Strategies, LLC
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    (a) o
                                                                                                                   (b) x
 
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
  NUMBER OF
  SHARES
  BENEFICIALLY
  OWNED BY
  EACH
5
SOLE VOTING POWER
 
0
  REPORTING
  PERSON WITH 
6
SHARED VOTING POWER
 
7,612,702
 
 
7
SOLE DISPOSITIVE POWER
 
0
 
 
8
SHARED DISPOSITIVE POWER
 
7,612,702
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,612,702
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* o
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
9.75%
 
12
TYPE OF REPORTING PERSON*
 
OO
 
 
* SEE INSTRUCTIONS BEFORE FILLING OUT!

 
 

 

CUSIP No. 00808Y109
13G
Page 4 of 7 Pages
 
1
NAME OF REPORTING PERSON
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
   
 
Steven Winters
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    (a) o
                                                                                                                   (b) x
 
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
  NUMBER OF
  SHARES
  BENEFICIALLY
  OWNED BY
  EACH
5
SOLE VOTING POWER
 
0
  REPORTING
  PERSON WITH 
6
SHARED VOTING POWER
 
7,612,702
 
 
7
SOLE DISPOSITIVE POWER
 
0
 
 
8
SHARED DISPOSITIVE POWER
 
7,612,702
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,612,702
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* o
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
9.75%
 
12
TYPE OF REPORTING PERSON*
 
OO
 
 
* SEE INSTRUCTIONS BEFORE FILLING OUT!

 
 

 

CUSIP No. 00808Y109
13G
Page 5 of 7 Pages
 
Item 1(a).
Name of Issuer:

Aethlon Medical, Inc.

Item 1(b). 
Address of Issuer's Principal Executive Offices:
 
8910 University Center Lane, Suite 660, San Diego, California 92122

Item 2(a).
Name of Persons Filing:
 
Gemini Master Fund, Ltd,
Gemini Strategies, LLC
Steven Winters

All of the securities covered by this report are owned directly by Gemini Master Fund, Ltd.  Gemini Strategies, LLC is the investment manager of Gemini Master Fund, Ltd., and Steven Winters is the sole managing member of Gemini Strategies, LLC.  As permitted by Rule 13d-4, the filing of this statement shall not be construed as an admission that either Gemini Strategies, LLC or Steven Winters is the beneficial owner of any of the securities covered by this statement, and each of Gemini Strategies, LLC and Steven Winters expressly disclaims any equitable or beneficial ownership of such securities.
 
Item 2(b).
Address of Principal Business Office or, if none, Residence:
 
Address for all filers:  c/o Gemini Strategies, LLC 135 Liverpool Drive, Suite C, Cardiff, CA 92007
 
Item 2(c).
Citizenship:

Gemini Master Fund, Ltd. was organized under the laws of the Cayman Islands. 
Gemini Strategies, LLC was formed under the laws of the State of Delaware
Steven Winters is a United States citizen.
 
Item 2(d).
Title of Class of Securities:

Common Stock, $0.001 par value

Item 2(e).
CUSIP Number:

00808Y109

Item 3.
If this statement is filed pursuant to rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
Not Applicable

 
 

 

CUSIP No. 00808Y109
13G
Page 6 of 7 Pages

Item 4.
Ownership:
 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 
(a)
Amount Beneficially Owned:  7,612,702 shares as of November 22, 2010
 
The Reporting Persons own a total of 7,612,702 shares of Common Stock, including (i) 286,483 shares of Common Stock (“Conversion Shares”) held by Gemini Master Fund, Ltd. (“Gemini”) issued to it on or about November 22, 2010; (ii) 3,078,947 shares of Common Stock issuable upon conversion of $660,000 in principal amount of the issuer’s Convertible Promissory Note (“Note”) issued to Gemini on or about February 12, 2010 (without any interest accrual and assuming a conversion price of $0.19); (iii) 2,727,272 shares of Common Stock issuable upon exercise of a warrant issued to Gemini on or about November 22, 2010; (iv) 200,000 shares of Common Stock issuable upon exercise of a warrant issued to Gemini on or about August 13, 2007; (v) 660,000 shares of Common Stock issuable upon exercise of a warrant issued to Gemini on or about January 18, 2008; and (vi) 660,000 shares of Common Stock issuable upon exercise of a warrant issued to Gemini on or about July 10, 2009.  Although the number of Conversion Shares may vary under the Note based on the conversion price thereunder, the number of shares of Common Stock into which the Note is convertible at any point in time is limited, pursuant to the terms of such instrument, to that number of shares of Common Stock which would result in the Reporting Persons having beneficial ownership of 9.9% of the total issued and outstanding shares of Common Stock (the "Ownership Limitation").  The Reporting Persons disclaim beneficial ownership of any and all shares of Common Stock that would cause any Reporting Person's beneficial ownership to exceed the Ownership Limitation.

 
(b)
Percent of Class:  9.75%

Based upon 70,476,081 shares of Common Stock outstanding as of November 15, 2010, as reported in the Issuer’s most recent quarterly report on Form 10-Q filed on November 15, 2010, plus the Conversion Shares, which were issued after such date.

 
(c)
Number of shares as to which such person has:
 
 
(i)
sole power to vote or to direct the vote:  0
 
 
(ii)
shared power to vote or to direct the vote:  7,612,702
 
 
(iii)
sole power to dispose or to direct the disposition of:  0
 
 
(iv)
shared power to dispose or to direct the disposition of:  7,612,702

Item 5.
Ownership of Five Percent or Less of a Class:
 
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6.
Ownership of More than Five Percent on Behalf of Another Person:

Not Applicable
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company of Control Person:

Not Applicable

Item 8.
Identification and Classification of Members of the Group:

Not Applicable

Item 9.
Notice of Dissolution of Group:
 
Not Applicable

 
 

 

CUSIP No. 00808Y109
13G
Page 7 of 7 Pages
 
Item 10.
Certification:
 
By signing below the undersigned certify that, to the best of its/his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE
 
After reasonable inquiry and to the best of its/his knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
 
December 2, 2010
 
GEMINI MASTER FUND, LTD.
By:
GEMINI STRATEGIES, LLC, as investment manager
       
 
By:
/s/ Steven Winters
 
 
Name:  Steven Winters
 
 
Title:    Managing Member
 
       
GEMINI STRATEGIES, LLC
       
By:
/s/ Steven Winters
 
Name:  Steven Winters
 
Title:    Managing Member
 
       
/s/ Steven Winters
 
Steven Winters
 

 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----